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Abstract We analyzed specific features of chondro-
cytes as cellular yield, cell doubling rates and the
dependence between these parameters and patient-
related data in a set of 211 osteoarthritic (OA) patients
undergoing total joint replacement. For each patient
the data available were joint type, age and gender.
Knee samples chosen randomly among all biopsies
were graded according to ICRS score. Patients’ age
ranged between 30 and 90 years with a mean age of
66 ± 9.7 years. Patients were divided into age classes
and statistically significant differences in proliferation
rate at passage 1 were found between chondrocytes
derived from young and old donors, with the last ones
characterized by a lower proliferation rate. A similar
trend was observed for proliferation rate at passage 2.
For all the samples, cellular yields ranged between 0.1
and 5.5 million cells/g of tissue. No significant corre-
lation was observed between the level of cartilage
degeneration (ICRS score) and cellular yield and
proliferation rates. However, in samples with a high
degree of cartilage degeneration (ICRS score 4) the
cellular yield was lower compared to the other three
groups (ICRS scores 1–3). In this study we performed a
systematic characterization of basic parameters of
chondrocytes originating from a wide group of OA
patients. Considering the use of autologous chondro-
cytes in chondral treatments, the characterization of
cell basic features may represent an important step to
determine the quality of the cell source which is a major
determinant in the outcome of cell-based therapies.
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Introduction
Osteoarthritis (OA) is a highly disabling pathology
which is worldwide investigated by the scientific
community due to its increasing diffusion. This age-
dependent degenerative disease induces the progres-
sive damage of articular cartilage and subchondral
bone and can eventually lead to the complete loss of
joint functionality (Aigner et al. 2004; van der Kraan
and van den Berg 2008). The combination of phar-
macological and non-pharmacological therapies has
been proved to be useful for the treatment of early- and
middle-stage OA patients, but a successful clinical
outcome is not granted when treating late-stage OA
patients (Zhang et al. 2008). In this category of
patients, the severe pain and the functional limitations
caused by advanced OA degeneration are currently
resolved mainly by joint replacement surgery.
In the last two decades, ‘‘advanced therapies’’ have
been intensely investigated in developed countries,
with the aim to find a biological solution to several
degenerative pathologies. In cartilage tissue engineer-
ing, a possible strategy for an autologous approach
would be to isolate chondrocytes from a cartilage
biopsy, to expand the cells and possibly cryopreserve
them for future re-intervention. Expanded chondro-
cytes are then seeded on a biomaterial and the
cellularized construct is finally implanted back to the
patient (Roseti et al. 2011). Cartilage tissue engineer-
ing applied to OA patients appears to be in contrast
with the controversial opinion that healthy autologous
chondrocytes or mesenchymal stem cells are neces-
sary to obtain healthy cartilage in vitro (Tran-Khanh
et al. 2005; van der Kraan and van den Berg 2008;
Wang et al. 2006). Recent works, however, have
demonstrated the possibility to use human OA chon-
drocytes to obtain autologous engineered cartilage
with properties similar to those of the constructs
obtained from non-OA chondrocytes (Carossino et al.
2007; Cavallo et al. 2010; Dehne et al. 2009;
Tallheden et al. 2005). Moreover, a recent work (Neri
et al. 2011) on human OA articular chondrocytes
characterized their genetic stability during long term
expansion, and demonstrated the safety of this cell
type for autologous advanced therapies. Since the
quality of cells used to generate the engineered tissue
greatly influences the outcome, a characterization of
OA chondrocytes in a wide patient group can help in
extending the validity of the reported results.
In this work we analyzed specific features of
chondrocytes collected from 211 osteoarthritic
patients undergoing total joint replacement. The
characteristics investigated were cellular yield and
cell doubling rates, and the dependence between these
parameters and some patients-related data.
Materials and methods
Chondrocyte isolation, expansion and data
collection
Samples of adult human articular cartilage were
harvested from subjects undergoing hip and knee
routine arthroplasty procedures. With the patient’s
informed consent and in respect to the privacy law, the
patient age, gender and joint type were recorded.
Based on evaluation by orthopaedic surgeons, random
knee samples were also graded from scores 1 to 4
using the ICRS protocol (Kleemann et al. 2005),
where higher scores indicate higher levels of cartilage
degeneration. Minced cartilage fragments (2–3 mm2)
were weighted and chondrocyte isolation was carried
out by cartilage digestion in 0.15 % collagenase type
II (Worthington) performed for 22 h at 37 C, as
previously described (Jakob et al. 2003).
Viable cells were counted by trypan blue dye
exclusion. Freshly isolated chondrocytes (P0) were
plated for expansion at a density of 1 9 104 cells/cm2
for the first passage (P1) and cultured with complete
proliferation medium (CM) containing Dulbecco’s
Modified Eagle Medium (DMEM) supplemented with
10 % fetal bovine serum (FBS, Lonza), 1 mM sodium
pyruvate, 100 mM HEPES buffer, 100 U/ml penicillin,
100 lg/ml streptomycin, 0.29 mg/ml L-glutamine,
1 ng/ml TGFb1, 5 ng/ml FGF-2 (PeproTech) (Barbero
et al. 2003). Where not otherwise specified, Invitrogen
products were used. For the second passage (P2) cells
were plated at a density of 0.5 9 104 cells/cm2. Cell
doubling rate (d) was calculated as
d ¼
log2
N
N0
 
t
ð1Þ
where N and N0 are the final and initial cell number,
respectively, and t is the expansion time. The cellular
yield was calculated as the ratio between the viable
cell number at P0, expressed in millions of cells, and
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the wet weight of the cartilage fragments, expressed in
grams.
Data processing and statistical analysis
The software Graph Pad Prism was used to order and
process the data. For each patient, the available data
were joint type, patient age, patient gender, ICRS
grading, cellular yield, doubling rate at P1 and at P2.
Mean and standard deviation were calculated for each
parameter and relative normalized frequency (2)
histograms were obtained. The normalized frequency
was calculated as
nf ¼ f
Sc  Ns ð2Þ
where f is the frequency of the data inside the
considered class, Sc is the spacing of the class and Ns
is the sample size (132 patients for the hip group, 88
patients for the knee group). Relative normalized
frequency histograms were also obtained for the
scored knee cartilage samples. For all the relative
normalized frequency histograms the Poisson distri-
bution was calculated.
Non normal distribution of data was determined
with a D’Agostino & Pearson normality test. Corre-
lation between patients’ age, cellular yield, and
proliferation rate at P1 and at P2 was determined
calculating the Spearman coefficient r and considered
significant for p \ 0.05. To compare independent
groups, Kruskal–Wallis test followed by Dunn’s
multiple comparison test was performed and differ-
ences were considered significant for p \ 0.05.
To better evaluate age-related differences in cellu-
lar yield and proliferation rate, patients were grouped
in the following age classes: B60, 65–70, C75 years,
composed of the same number of patients (n = 47).
Four years gaps between classes were left to avoid
overlapping.
Box-plots were used for the visualization of the
main parameters of the data statistical distribution both
for age classes and for ICRS score groups (minimum,
25th percentile, 75th percentile, maximum).
Results
Patients’ gender distribution showed that 42 % of hip
arthroplasties were performed on males and 58 % on
females (Fig. 1). For knee arthroplasties the percentage
of male versus female patients was 12 % versus 88 %.
Considering both arthroplasty types together, female
patients were 69 % of the total. Patients’ age ranged
between 30 and 90 years and the frequency histograms
showed a mean age of 66 years, both for knee and hip
patients (Fig. 2a–c). The ICRS grading system was
applied to samples of knee cartilage randomly chosen
among the donors, to classify the samples from scores 1
(low damage) to 4 (high damage). The mean age of
patients did not differ significantly between scores and
ranged from 65 to 69 years, as shown in frequency
distribution graphs in Fig. 2d–g.
Cellular yield values ranged between 0.1 and
5.5 million cells/g of tissue, with a mean of 1.85 ±
1.37 and 1.62 ± 1.08 million cells/g of tissue for hip
and knee samples, respectively (Fig. 3a–c). For the
different ICRS scores, mean values of cellular yield
were similar up to score 3 (about 1.4 million cells/g of
tissue), whereas it was lower for highly degenerated
tissue (score 4, 0.9 million cells/g of tissue).
The analysis of the correlation between patients’
age, cellular yield and proliferation rate at P1 and at P2
Males 
[%]
Females 
[%]
Hip patients 42% 58%
Knee patients 12% 88%
Total patients 31% 69%
Fig. 1 Frequency distribution of patient gender. The patients, all affected by osteoarthritis, were subjected to total hip or knee
replacement
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Fig. 2 Relative normalized frequency distribution obtained for increasing classes of patient age for the hip (a), knee (b), total (c) and
increasing ICRS scores (d–g). The frequency histograms are approximated by Poisson’s distribution
Fig. 3 Relative normalized frequency distribution obtained for increasing classes of cellular yield for the hip (a), knee (b), total (c) and
increasing ICRS scores (d–g). The frequency histograms are approximated by Poisson’s distribution
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are reported in Fig. 4 with the corresponding correla-
tion coefficients (Spearman r). Significant correlations
were observed between age and doubling rate at P1
(r = -0.223, p \ 0.01), showing a decrease of dou-
bling rate at P1 with increasing age, and between
doubling rate at P2 and at P1 (r = 0.343, p \ 0.001),
demonstrating a trend between cell growth at both
passages. A significant correlation was found also
between cellular yield and proliferation rate at P2
(r = 0.268, p \ 0.001), suggesting that cells deriving
from samples with a higher cellular yield, retain a
greater proliferation potential during expansion.
Pair wise comparison of data, grouped on the basis
of patient age classes, homogeneous in size, are shown
in Fig. 5. The average cellular yield did not signifi-
cantly differ between age classes (Fig. 5a). We found
statistically significant differences on proliferation
rates at P1 between the age class B60 as compared to
Fig. 4 Correlations among individual data groups. a Cellular
yield versus patient age, b proliferation rate at P1 versus patient
age, c proliferation rate at P2 versus patient age, d proliferation
rate at P1 versus cellular yield, e proliferation rate at P2 versus
cellular yield and f proliferation rate at P2 versus proliferation
rate at P1. Correlation coefficients (Spearman r) are indicated in
each graph. **p \ 0.01, ***p \ 0.001
Fig. 5 Box plots showing pair-wise comparisons of grouped
data pertaining to patient age and cellular yield classes
homogeneous in size. a Cellular yield versus patient age,
b proliferation rate at P1 versus patient age, c proliferation rate
at P2 versus patient age. The values delimiting the box in the box
plots are the 25th and 75th percentiles of the data distribution.
*p \ 0.05
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the C75, which was characterized by the lowest
proliferation rate (Fig. 5b). Proliferation rates at P2
were higher than at P1, independently from the patient
age (Fig. 5c).
No significant correlation was found among ICRS
scores, cellular yields and proliferation rates at P1 and
P2, as shown in Fig. 6. However, as the cartilage
damage level increased, the mean cellular yield
slightly decreased, whereas the proliferation rates did
not differ with increasing scores. As already observed
for data on hip and knee population, proliferation rates
at P2 were higher than the rates at P1.
Discussion
OA is fully recognized as an age-dependent degener-
ative disease (Loeser et al. 2012). Considering the high
and increasing life expectancy in developed countries,
osteoarthritis is assuming an important social effect.
Coherently, countermeasures to OA such as cellular
therapies are intensely investigated (Goldring and
Goldring 2007). In this study, adult human articular
chondrocytes were isolated from anatomical speci-
mens discarded during total joint replacement, with the
aim to characterize them in view of their potential use
as source for autologous cell therapy. More than 200
OA patients were included in this analysis, which
required, for our institution, a period of 4 years for data
collection. Accordingly with literature (Cicuttini et al.
2003; Musumeci et al. 2011; Wluka et al. 2001) we
found that the majority of patients subjected to total
joint replacement were postmenopausal women. The
age of patients in our analysis ranged from 30 to
90 years old, but the frequency distributions showed
that the highest amount of patients belonged to the
range 65–70 years. The pair-wise analysis of data on
cellular yield and proliferation rates showed that the
patient age is not statistically correlated to the cellular
yield, as in (Bobacz et al. 2004), but was negatively
correlated with the proliferation rate at P1, which
followed a trend analogue to the proliferation rate at
P2. As already reported in the literature (Barbero et al.
2004) for healthy chondrocytes, the most relevant
reduction in cellular yield is observed between patients
younger than 40 years and older patients, then with
increasing age this feature remains almost constant.
75 % of our patients are older than 63 years: this could
explain the lack of significant influence of patient age
on cellular yield. In accordance with previously
published data on healthy chondrocytes (Dozin et al.
2002), cell proliferation significantly decreased with
increasing age at P1, but this significant correlation was
not found between age and doubling rate at P2. A
possible explanation can be found in the use of TGFb1
and FGF2, growth factors able to increase the prolif-
eration rate and to maintain the chondrocyte phenotype
during the expansion procedures. This property is
particularly useful when large amounts of cells are
needed requiring a long-term expansion (Barbero et al.
2003). Thanks to the use of TGFb1 and FGF-2,
chondrocytes started soon to proliferate. The offset
difference in cell proliferation rates that we found
between P1 and P2 is in accordance with previous work
(Barlic et al. 2008; Lin et al. 2006) and can be attributed
to an initial lag phase where cells recover from
isolation procedure. Interestingly, however, a relation-
ship between the proliferation rate at P1 and at P2 was
found in our data suggesting that cells with the lowest
proliferation rate at P1 were also less proliferative at P2
and that the cells with high proliferation rate at P1
maintained this feature at P2.
Fig. 6 Box plots (a–c) for the ICRS-scored knee cartilage samples. The values delimiting the box in the box plots are the 25th and 75th
percentiles of the data distribution
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To correlate analyzed cellular parameters with the
grade of cartilage degeneration, we evaluated random
samples scored on the basis of ICRS scale. A lower
cellular yield was observed in score 4 specimens. This
result can be attributed to the higher degeneration
level of this tissue whereby the inflammatory state of
the tissue can affect cellularity. The proliferation rates
for samples with different scores are in accordance
with previously reported results (Yin et al. 2011):
score has a slight influence only on the initial phase of
in vitro expansion, whereas cell proliferation during
the subsequent passages was independent from the
degeneration of the excised cartilage.
In conclusion, our study allowed a systematic
characterization of basic parameters as cellular yield
and proliferation rates of chondrocytes originating from
a wide group of OA patients. This characterization could
be useful in view of a possible autologous cell therapy
approach for osteoarthritis, as it is fundamental to
determine the quality of the cell source, known to
greatly influence the outcome of engineered tissue.
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